Can High-Tech eye exams save sight in underserved communities?

NCT ID NCT06934577

Recruiting now Diagnosis Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a technology-enhanced eye exam to a standard optometric exam for detecting three leading causes of blindness: glaucoma, diabetic retinopathy, and cataracts. About 900 adults at a Federally Qualified Health Center will be randomly assigned to one of the two exams. The goal is to see which method finds more vision-threatening eye disease, especially in communities with limited access to eye care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Technology-enhanced eye disease detection protocol
What this could lead to: If successful, this approach could improve early detection of blinding eye diseases in underserved communities, potentially reducing vision loss.
What could go wrong: This is a pragmatic trial comparing two screening methods, not testing a new treatment. The technology-enhanced protocol may not detect more disease than standard care, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic retinopathy eye disorder glaucoma vision disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EYE DISEASES GLAUCOMA VISUAL IMPAIRMENT

Contacts and locations

Locations

Hamilton Optometry Clinic
RECRUITING

Flint, Michigan, 48505., United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.